Q1 2016 13F Holders as of 31 Mar 2016
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
5,172,213
-
Share change
-
+167,012
-
Total reported value
-
$9,367,000
-
Price per share
-
$1.81
-
Number of holders
-
21
-
Value change
-
+$329,459
-
Number of buys
-
8
-
Number of sells
-
7
Institutional Holders of CORBUS PHARMACEUTICALS HLDGS - COM (CRBP) as of Q1 2016
As of 31 Mar 2016,
CORBUS PHARMACEUTICALS HLDGS - COM (CRBP) was held by
21 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
5,172,213 shares.
The largest 10 holders included
Knoll Capital Management, LP, PERCEPTIVE ADVISORS LLC, VANGUARD GROUP INC, Raymond James Financial Services Advisors, Inc., BlackRock Institutional Trust Company, N.A., GEODE CAPITAL MANAGEMENT, LLC, RAYMOND JAMES & ASSOCIATES, RENAISSANCE TECHNOLOGIES LLC, BlackRock Fund Advisors, and Yellowstone Partners, LLC.
This page lists
21
institutional shareholders reporting positions in this security
for the Q1 2016 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.